Status and phase
Conditions
Treatments
About
This study evaluates the safety and efficacy of QTORIN 3.9% rapamycin anhydrous gel in the treatment of adults with Pachyonychia Congenita. This study includes a screening period, baseline period and 6-month treatment period.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
87 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Emily Cook
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal